LTF and metabolic disease: The first evidence for the association between endogenous circulating Lf and metabolic disorders was provided by two studies by Fernandez-Real and colleagues, who analyzed the concentration of circulating Lf in patients suffering from insulin resistance and altered glucose tolerance (AGT) [80,81].